CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
Autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis, involve dysregulated immune responses causing chronic inflammation and tissue damage. Despite advancements in clinical management, many patients do not respond to current treatme...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-12-01
|
| シリーズ: | Frontiers in Immunology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1502712/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
